Silk science for advanced regeneration


Life Sciences

Anzu Investment:

September 2019

Unlocking the potential of biomedical silk protein in soft tissue regeneration

Sofregen provides medical practitioners with natural biomaterials to enhance their surgical artistry and achieve more durable results for their patients. 

The company aims to unlock the enormous potential of purified silk protein to facilitate soft tissue regeneration for a range of aesthetic procedures and surgeries including vocal fold medialization and insufficiency.
Silk Voice® Injectable Implant , a breakthrough silk and hyaluronic acid injectable implant, was cleared by the U.S. FDA  in 2019. Silk Voice® is indicated for vocal fold medialization and vocal fold insufficiency that may be improved by injection of a soft tissue bulking agent.
SERI® Surgical Scaffold, a breakthrough silk-based implantable biological scaffold, was cleared by the U.S. FDA  in 2013. Sofregen acquired SERI® Surgical Scaffold in late 2016 to advance this technology and other silk protein-based pipeline products in a broad range of aesthetic procedures requiring tissue support.

Interested in more information?

Complete the form below to get connected directly with the portfolio company